We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24B
AUM Growth
$0
Cap. Flow
-$3.42M
Cap. Flow %
-0.01%
Top 10 Hldgs %
15.39%
Holding
2,661
New
–
Increased
–
Reduced
9
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.05M
2
FISV
Fiserv Inc
FISV
+$646K
3
BF.B icon
Brown-Forman Class B
BF.B
+$479K
4
BF.A icon
Brown-Forman Class A
BF.A
+$84.1K
5
NEOG icon
Neogen
NEOG
+$73.5K

Sector Composition

Rank Sector Weight
1 Technology 16.3%
2 Healthcare 16.1%
3 Financials 12.91%
4 Industrials 10.68%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBHT icon
826
JB Hunt Transport Services
JBHT
$26.1B
$463K ﹤0.01%
4,033
– –
EV
827
DELISTED
Eaton Vance Corp.
EV
$459K ﹤0.01%
8,140
– –
VSM
828
DELISTED
Versum Materials, Inc.
VSM
$459K ﹤0.01%
12,137
– –
TRCB
829
DELISTED
Two River Bancorp
TRCB
$455K ﹤0.01%
25,120
– –
HIT
830
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$452K ﹤0.01%
5,807
– –
PB icon
831
Prosperity Bancshares
PB
$8.82B
$450K ﹤0.01%
6,448
– –
NCLH icon
832
Norwegian Cruise Line
NCLH
$9.74B
$443K ﹤0.01%
8,325
– –
EXPO icon
833
Exponent
EXPO
$3.15B
$442K ﹤0.01%
12,462
– –
WP
834
DELISTED
Worldpay, Inc.
WP
$435K ﹤0.01%
5,930
– –
HUBS icon
835
HubSpot
HUBS
$12.2B
$431K ﹤0.01%
4,883
– –
TEVA icon
836
Teva Pharmaceuticals
TEVA
$36.9B
$429K ﹤0.01%
22,669
– –
ACGL icon
837
Arch Capital
ACGL
$37.2B
$426K ﹤0.01%
14,112
– –
SGEN
838
DELISTED
Seagen Inc. Common Stock
SGEN
$425K ﹤0.01%
7,952
– –
BF.A icon
839
Brown-Forman Class A
BF.A
$13.4B
$422K ﹤0.01%
6,298
-1,575
-20% -$84.1K
RY icon
840
Royal Bank of Canada
RY
$295B
$422K ﹤0.01%
5,185
– –
MORN icon
841
Morningstar
MORN
$7.38B
$420K ﹤0.01%
4,341
– –
ITT icon
842
ITT
ITT
$17.8B
$418K ﹤0.01%
7,862
– –
TXT icon
843
Textron
TXT
$15.6B
$417K ﹤0.01%
7,377
– –
BG icon
844
Bunge Global
BG
$22.8B
$415K ﹤0.01%
6,205
– –
XLNX
845
DELISTED
Xilinx Inc
XLNX
$411K ﹤0.01%
6,107
– –
SNP
846
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$410K ﹤0.01%
5,595
– –
TAL icon
847
TAL Education Group
TAL
$5.79B
$408K ﹤0.01%
13,765
– –
LBTYK icon
848
Liberty Global Class C
LBTYK
$3.4B
$406K ﹤0.01%
12,045
– –
HSBC.PRA
849
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$405K ﹤0.01%
15,725
– –
IVR icon
850
Invesco Mortgage Capital
IVR
$769M
$401K ﹤0.01%
2,256
– –
32 33
34
35 36

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2018 Portfolio in Review

As of Q1 2018, Glenmede Trust held 2,661 positions worth $24B, unchanged from the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 2,661-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, unchanged from a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's biggest Q1 2018 reduction was Aflac, cutting an estimated $2.05M.
  • Glenmede Trust's ten largest holdings make up 15% of its $24B portfolio in Q1 2018.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2018.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $24B.

Based on Glenmede Trust's 13F filing for Q1 2018, filed 15 May 2018.